Director Rajat Taneja reported the acquisition of 3,565 restricted stock units of Oscar Health, Inc. (NYSE:OSCR) in a filing submitted on November 17, 2026, reflecting a transaction dated November 13, 2026.

Key Highlights

  • Reporting person: Rajat Taneja, identified as a Director of Oscar Health, Inc.
  • Transaction: Acquisition of 3,565 shares of Class A Common Stock via restricted stock units (RSUs), coded as an award (A)
  • Transaction price: $0 per RSU, as reported in the filing
  • Resulting ownership: 3,565 shares of Class A Common Stock beneficially owned directly following the transaction
  • Vesting condition: RSUs vest on the earlier of the one-year anniversary of the grant date or the date of the next annual stockholder meeting, subject to continued service
  • Settlement terms: Vested RSUs settle in Class A Common Stock on the earliest of the six-month anniversary of separation from service, death or disability, or within five days of a change in control

Oscar Health Director Taneja Awarded RSUs in November 2026 Grant

According to the filing, Rajat Taneja, a director of Oscar Health, Inc., received 3,565 restricted stock units on November 13, 2026. Each RSU, the filing states, "represents a contingent right to receive one share of Oscar Health, Inc. Class A common stock." The transaction was recorded at a price of $0 and resulted in direct beneficial ownership of 3,565 shares following the reported transaction. No prior holdings were listed in the filing before this grant.

Oscar Health, Inc. is a health insurance company that trades on the New York Stock Exchange under the ticker OSCR. The filing describes the vesting schedule as the earlier of two dates: the one-year anniversary of the grant date, or the date of the next annual meeting of stockholders, in each case subject to Taneja's continued service through the applicable vesting date. Settlement in Class A Common Stock occurs on the earliest of the six-month anniversary of separation from service, death or disability, or within five days following a change in control of the issuer, according to the filing's explanation of responses.

The filing was signed by Melissa Curtin as Attorney-in-Fact on November 17, 2026. No derivative securities were reported in Table II of the filing, and no amendment date was noted, indicating this was an original filing rather than a correction to a prior submission.

What Was Disclosed

Director Rajat Taneja reported receiving 3,565 RSUs of Oscar Health, Inc. Class A Common Stock on November 13, 2026, at $0 per unit, leaving him with direct beneficial ownership of 3,565 shares. The RSUs are subject to service-based vesting conditions described in the filing.